In Massachusetts, GenePeeks, Inc. has a new President and Chief Commercial Officer, Matt Posard, who comes with over 25 years of experience at a variety of genomic and life sciences companies including Illumina, Inc., Trovagene, Inc. and Alere, Inc. His role at GenePeeks will be to head up commercialization of their computational genomics products and services. Their patented Virtual Progeny Analytics product takes the genetic makeup of two parents and computationally predicts what diseases or health issues their child will be at risk for, genetically speaking, before they even conceive a baby. Many parents want to know the risks before they conceive, especially for serious diseases, so they can be more prepared for the possibilities.
Latest article
Dutch Queen promotes biobased building materials
In the Netherlands, Dutch Queen consort Máxima visited two Uden worksites promoting biobased building materials made from Netherlands fiber crops.
The March 26 visit...
ReefCircular launches crowdfunding campaign for shell bioconcrete
In Denmark, ReefCircular, a company developing a shell-based bioconcrete to help restore marine habitats, has launched a crowdfunding campaign on Kickstarter.
The company’s bioconcrete...
Aleph Farms raises $29 million for lab-grown steak
In Israel, cultivated meat producer Aleph Farms has raised $29 million to expand production at its Rehovot pilot plant and expand production into Europe...